Sepracor Plans Alvesco, Omnaris Drug Launches Following Acquisition From Nycomed
Sepracor’s 1,600-person sales force will promote the asthma and allergic rhinitis treatments.
Sepracor’s 1,600-person sales force will promote the asthma and allergic rhinitis treatments.